Cargando…
Correction to “Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein–Protein Interaction”
Autores principales: | Pallesen, Jakob S., Munier, Claire C., Bosica, Francesco, Andrei, Sebastian A., Edman, Karl, Gunnarsson, Anders, La Sala, Giuseppina, Putra, Okky Dwichandra, Srdanović, Sonja, Wilson, Andrew J., Wissler, Lisa, Ottmann, Christian, Perry, Matthew W. D., O’Mahony, Gavin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923739/ https://www.ncbi.nlm.nih.gov/pubmed/36708352 http://dx.doi.org/10.1021/acs.jmedchem.3c00076 |
Ejemplares similares
-
Designing Selective
Drug-like Molecular Glues for
the Glucocorticoid Receptor/14-3-3 Protein–Protein Interaction
por: Pallesen, Jakob S., et al.
Publicado: (2022) -
Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14-3-3 protein regulators
por: Munier, Claire C., et al.
Publicado: (2021) -
Identification of molecular glues of the SLP76/14-3-3 protein–protein interaction
por: Soini, Lorenzo, et al.
Publicado: (2021) -
A new solvate of epalerstat, a drug for diabetic neuropathy
por: Putra, Okky Dwichandra, et al.
Publicado: (2017) -
Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
por: Umeda, Daiki, et al.
Publicado: (2017)